Phase I trial of deuperfenidone (SD 560) in volunteers

Trial Profile

Phase I trial of deuperfenidone (SD 560) in volunteers

Phase of Trial: Phase I

Latest Information Update: 27 Jan 2015

At a glance

  • Drugs Deupirfenidone (Primary) ; Pirfenidone (Primary)
  • Indications Fibrosis; Idiopathic pulmonary fibrosis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 27 Jan 2015 Status changed from planning to recruiting, according to the Auspex Pharmaceuticals website.
    • 01 Apr 2014 New trial record
    • 25 Mar 2014 Early trial results are expected in 2015 according to an Auspex Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top